Theme
Diagnostics '26: Cancer Screening & Early Detection☆
8 tickers$208.22B market cap
Group: Diagnostics

GRAL+96.94%25.0%

GH+203.57%15.0%

LUCD—15.0%

ABT-23.03%12.0%

300676.SHE-17.53%11.0%

000710.SHE-30.30%8.0%

BNR+75.09%8.0%

VNRX—6.0%
As of Sep 18, 2026, 9:54 PM ET
Diagnostics '26: Cancer Screening & Early Detection Constituents
GRAIL Inc.GRAL | 25.0% | 1.03% | -1.43% | 9.99% | -2.28% | -8.90% | 46.48% | 198.28% | 96.94% | 482.34% | 297.49% | $3.47B |
Guardant Health, Inc.GH | 15.0% | -2.03% | 10.88% | 11.48% | 8.57% | 74.76% | 90.10% | 310.44% | 203.57% | 606.50% | 35.84% | $24.07B |
Lucid Diagnostics Inc.LUCD | 15.0% | — | — | — | — | — | — | — | — | -4.03% | — | $149.9M |
Abbott LaboratoriesABT | 12.0% | 0.35% | -2.77% | -8.95% | -5.82% | -17.70% | -11.82% | -20.78% | -23.03% | -7.50% | -11.99% | $177.55B |
BGI Genomics Co., Ltd.300676.SHE | 11.0% | 6.41% | 6.51% | 2.06% | 2.76% | -8.74% | -16.45% | -19.26% | -17.53% | 20.32% | -57.32% | $2.48B |
Berry Genomics Co.,Ltd000710.SHE | 8.0% | 5.97% | 1.75% | 2.00% | -0.89% | -16.42% | -25.54% | -28.94% | -30.30% | 33.65% | -62.86% | $477.3M |
Burning Rock Biotech LimitedBNR | 8.0% | 8.80% | 37.49% | 58.16% | 59.71% | -26.92% | -42.99% | 244.85% | 75.09% | 309.40% | -93.03% | $15.0M |
VolitionRX LtdVNRX | 6.0% | — | — | — | — | — | — | — | — | -97.95% | -99.59% | $2.2M |
| Average | 12.5% | 3.42% | 8.74% | 12.46% | 10.34% | -0.65% | 6.63% | 114.10% | 50.79% | 167.84% | 1.22% | $26.03B |
| Median | 11.5% | 3.50% | 4.13% | 6.03% | 0.93% | -12.66% | -14.13% | 89.51% | 28.78% | 26.99% | -57.32% | $1.48B |
| Std Dev | 5.6% | 3.86% | 13.67% | 21.49% | 22.53% | 34.28% | 46.41% | 140.93% | 84.41% | 245.48% | 128.58% | $57.78B |
| Min | 6.0% | -2.03% | -2.77% | -8.95% | -5.82% | -26.92% | -42.99% | -28.94% | -30.30% | -97.95% | -99.59% | $2.2M |
| Max | 25.0% | 8.80% | 37.49% | 58.16% | 59.71% | 74.76% | 90.10% | 310.44% | 203.57% | 606.50% | 297.49% | $177.55B |
| % Positive Tickers | 83.33% | 66.67% | 83.33% | 50.00% | 16.67% | 33.33% | 50.00% | 50.00% | 62.50% | 28.57% |
About this theme
Diagnostics '26: Cancer Screening & Early Detection tracks 8 publicly listed stocks in this theme: GRAL, GH, LUCD, ABT, 300676.SHE, 000710.SHE, BNR, VNRX. See the constituent table for details.